Position in CABA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,878,775
+$4,771,914 QoQ
Shares Held
2,211,825
+182.4% QoQ
Ownership
1.30%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 139 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 98%
Shared 1%
None 0%
Common Shares in CABA Over Time
Shares Held
Position Value (USD)
Derivatives in CABA
reported options exposure · as of Mar 31, 2026CallValue
$663,085
CallShares
246,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. CABA ranks #175 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in CABA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,878,775 | 2,211,825 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $663,085 | 246,500 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $2,106,861 | 783,220 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $943,176 | 430,674 | Shares | Defined | 2026-03-25 | |
| 2025-12-31 | $539,835 | 246,500 | Call | Defined | 2026-03-25 | |
| 2025-09-30 | $637,874 | 272,596 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $537,026 | 353,307 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $457,798 | 330,541 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,161,138 | 511,515 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,516,814 | 321,359 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,960,755 | 395,823 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,253,467 | 425,174 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,405,709 | 238,137 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $4,566,790 | 300,052 | Shares | Defined | 2024-05-15 | |
| 2023-03-31 | $1,336,398 | 161,596 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $7,147 | 10,996 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $14,781 | 13,945 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $28,133 | 13,859 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $49,929 | 13,174 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $522,478 | 42,967 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $304,207 | 35,373 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $498,245 | 44,887 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $392,870 | 31,480 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $271,747 | 25,069 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $318,604 | 28,600 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $184,711 | 25,303 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||